Evidence map›Paper›PMID 35725726›Full record

ArticleNature communications2022

Inhibition of negative feedback for persistent epithelial cell-cell junction contraction by p21-activated kinase 3.

Hiroyuki Uechi, Kazuki Fukushima, Ryota Shirasawa, Sayaka Sekine, Erina Kuranaga

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroyuki UechiLaboratory for Histogenetic Dynamics, Graduate School of Life Sciences, Tohoku University, 6-3, Aramaki-aza-aoba, Aoba-ku, Sendai, 980-8578, Japan.
Kazuki FukushimaLaboratory for Histogenetic Dynamics, Graduate School of Life Sciences, Tohoku University, 6-3, Aramaki-aza-aoba, Aoba-ku, Sendai, 980-8578, Japan.ORCID 0000-0001-6090-5256
Ryota ShirasawaLaboratory for Histogenetic Dynamics, Graduate School of Life Sciences, Tohoku University, 6-3, Aramaki-aza-aoba, Aoba-ku, Sendai, 980-8578, Japan.
Sayaka SekineLaboratory for Histogenetic Dynamics, Graduate School of Life Sciences, Tohoku University, 6-3, Aramaki-aza-aoba, Aoba-ku, Sendai, 980-8578, Japan.ORCID 0000-0001-5656-2959
Erina KuranagaLaboratory for Histogenetic Dynamics, Graduate School of Life Sciences, Tohoku University, 6-3, Aramaki-aza-aoba, Aoba-ku, Sendai, 980-8578, Japan. erina.kuranaga.d1@tohoku.ac.jp.ORCID 0000-0001-6300-2087

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actin-mediated mechanical forces are central drivers of cellular dynamics. They generate protrusive and contractile dynamics, the latter of which are induced in concert with myosin II bundled at the site of contraction. These dynamics emerge concomitantly in tissues and even each cell; thus, the tight regulation of such bidirectional forces is important for proper cellular deformation. Here, we show that contractile dynamics can eventually disturb cell-cell junction contraction in the absence of p21-activated kinase 3 (Pak3). Upon Pak3 depletion, contractility induces the formation of abnormal actin protrusions at the shortening junctions, which causes decrease in E-cadherin levels at the adherens junctions and mislocalization of myosin II at the junctions before they enough shorten, compromising completion of junction shortening. Overexpressing E-cadherin restores myosin II distribution closely placed at the junctions and junction contraction. Our results suggest that contractility both induces and perturbs junction contraction and that the attenuation of such perturbations by Pak3 facilitates persistent junction shortening.

Indexed as

Actinsp21-Activated KinasesAdherens JunctionsCadherinsEpithelial CellsFeedbackIntercellular JunctionsMyosin Type IITight JunctionsActinsCadherinsMyosin Type IIp21-Activated Kinases

Identifiers

PMID35725726
PMCPMC9209458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.